Author

Sandra Boiziau

Observed name: boiziau, sandra

Institution: Ipsen (France)

Observed institution: Ipsen (France)

ORCID: 0000-0001-8208-6490

Observed ORCID: 0000-0001-8208-6490

OpenAlex ID: A5005335512

PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly

2022 · Dermot O’Toole, Pamela L. Kunz, et al. · Advances in Therapy · 17

Correction to: PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly

2024 · Dermot O’Toole, Pamela L. Kunz, et al. · Advances in Therapy

PMON57 Impact of Injection Modalities on Real-World Injection Experience in Patients with Acromegaly or Neuroendocrine Tumors (NETs) Treated With Somatostatin Analog (SSA) Therapy: Data from the PRESTO 2 Survey

2022 · Antonio Ribeiro-Oliveira, Dermot O’toole, et al. · Journal of the Endocrine Society

Real-world injection experience and use of independent injection among patients using lanreotide autogel/depot (LAN) prefilled syringe or octreotide long-acting release (OCT) to treat acromegaly or neuroendocrine tumors (NETs): international PRESTO 2 survey

2022 · Susan Webb, Dermot O'Toole, et al. · Endocrine Abstracts

Works count: 5

Citation count: 17

H-index: 1

I10-index: 1